Clinical trial
Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
NCT06854107 is registered in ClinicalTrials.gov with Zilong Yuan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
- Lead sponsor
- Zilong Yuan
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2023
- Completion date
- December 1, 2023
- Enrollment
- 225 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.